The impact of over ten years of HPV vaccination in England: Surveillance of type-specific HPV in young sexually active females

This publication has 25 references indexed in Scilit:

• Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation
  The Journal of Infectious Diseases, 2013
• A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
  Vaccine, 2012
• Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
  The Lancet Infectious Diseases, 2012
• Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
  The Lancet Oncology, 2012
• 11. Cancers attributable to infection in the UK in 2010
  British Journal of Cancer, 2011
• Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males
  Journal of Medical Virology, 2011
• Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom
  Vaccine, 2010
• The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
  The Journal of Infectious Diseases, 2009
• Economic evaluation of human papillomavirus vaccination in the United Kingdom
  BMJ, 2008
• Chapter 2: The burden of HPV-related cancers
  Vaccine, 2006